Volume 11, Number 6—June 2005
Dispatch
Community-associated Methicillin-resistant Staphylococcus aureus, Switzerland
Table
Characteristic | Patients with CA-MRSA (n = 13) (%) | Patients without MRSA (n = 1,542) (%) | p value* | Patients with healthcare-associated MRSA (n = 346) (%) | p value† |
---|---|---|---|---|---|
Mean age (y ± SD) | 45 ± 25 | 70 ± 18 | <0.001 | 75 ± 15 | <0.001 |
Male sex | 6 (46) | 682 (44) | 1.0 | 199 (58) | 0.57 |
Residency outside Switzerland | 6 (46) | 10 (1) | <0.001 | 8 (2) | <0.001 |
Healthcare worker | 0 (0) | 31 (2) | 1.0 | 3 (1) | 1.0 |
Emergency admission | 9 (69) | 724 (48) | 0.17 | 166 (48) | 0.16 |
Severity of disease | |||||
Presence of ≥1 coexisting condition | 8 (62) | 1,082 (70) | 0.55 | 289 (84) | 0.05 |
Rapidly or ultimately fatal disease | 0 | 277 (18) | 0.11 | 95 (27) | 0.02 |
Complete dependence for daily activities | 0 | 114 (7) | 0.62 | 57 (16) | 0.24 |
Antimicrobial drug exposure | |||||
Previous exposure (<6 mo) | 1 (8) | 318 (21) | 0.49 | 197 (57) | <0.001 |
Current use at admission | 3 (23) | 148 (10) | 0.13 | 41 (12) | 0.21 |
Presence at admission of indwelling urinary catheter | 0 | 73 (5) | 1.0 | 64 (19) | 0.14 |
Open skin lesions | 2 (15) | 100 (6) | 0.21 | 65 (19) | 1.0 |
*Community-associated MRSA case-patients versus non-MRSA controls.
†Community-associated MRSA case-patients versus controls with healthcare-associated MRSA strains (SCCmec type I isolates).
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.